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PORTAL HYPERTENSION 
Definition 
BY 1. G. CLARK 
Based on a Dissertation read before the Royal 
Medical Society on Friday, 15th January 1960. 
Portal hypertension is a condition of chronically raised pressure in the 
portal venous system, giving rise to splenomegaly and the development of 
enlarged collateral venous channels connecting the portal and systemic 
circulatory systems. 
Anatomy 
Figure I illustrates the disposition of the main veins of the portal system. 
and indicates the chief sites at which this system communicates with the 
systemic veins. The presence of a Caput Medusae in cases of intrahepatic 
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obstruction, and its absence in extrahepatic obstruction. is evident from W K H 
drawing. Not all of these sites are important clinically or diagnostically. 
but their total capacity causes a very considerable volume of blood to bypass 
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the liver and be released into the general circulation when the communications 
arc enlarged. . . . . 
The vascular structure of the hver is Important, and I have rllustrated 
this with a diagram (Figure 2) on which it is readily seen how easily 
inflammatory and fibrotic processes can F D X V H  obstruction of I O R Z and there-
fore raised portal pressure. Understandmg of this structure is fundamental 
to the comprehension R I Jiver S D W K R O R J \  
and the clinical conditions to which It 
can give rise. 
Physiology 
There is no justification for D W W H P S W 
ing to include here the ocean of hepatic 
physiology in the sea . of_ portal hyper-
tension, and I shall hrmt my remarks 
to three subjects. 
Firstly, in the realm of biochemistry. 
protein metabolism is of greatest interest 
in this condition, but it will be more 
convenient to discuss that later on in 
connection with portal neuropathy. 
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Second, blood flow. The amount of 
blood reaching the liver is controlled by 
the sympathetic system operating L Q  W K H
gut. This variable input is dealt Z L W K  m 
the hepatic vascular bed by a mechamsm 
which is as yet ill-understood. It has 
been shown in rats that the area of liver 
bed in use at any one time is controlled BILE $ 1 $ / , & 8 / 8 6 
by means of opening and closing of _the 
peripheral par_ts o f  it. The P H F K D Q L V P INTRAHEPATICHEPATICCIRCULATIONON 
by whtch this IS perpetrated Is Q R W  . 
known, and the existence of porta-hepatic Fig. 2 
communications has been proposed by some workers and denied by 
others. 
Total liver blood flow in a normal adult has been shown to be about 
1600 ml./min. 
Third, portal pressure. This can be measured in three ways:-
(a) Canulation of an omental vein at operation. 
(b) Percutaneous splenic puncture. 
(c) Wedge manometry of hepatic venous radicals. 
The third method can only be done at a well equipped cardiology centre. 
Normal portal pressure is 10-16 cm. of saline, as measured by omental 
canulation, and a little higher on splenic puncture (12-20 cm. of saline). 
Temporary occlusion of the portal vein in a normal subject will cause the 
pressure to rise to 50 cm. saline, and pressures of 20-50 cm. saline arc 
typical of portal hypertension. 
Pathology 
Causal conditions may be divided into three groups:-
(a) Prehepatic venous occlusion, from within or without. 
(b) Intrahepatic sinusoidal obstruction. by inflammation or fibrosis-
% of cases. 
(c) Post-hepatic venous occlusion-very rare. 
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Space does not permit me to give details. which can be discovered in 
any text-book on pathology. The pathological changes due to portal hyper-
tension are as follows : 
(I) Varices- -By far the most important of these are oesophageal 
varices. but, rarely, varices in the falciform ligament give rise 
to the interesting Cruveilhier-Baumgarten syndrome, and retro-
peritoneal varices may rupture giving a massive fatal haemo-
peritoneum. Haemorrhoids. for some unknown reason which 
apparently defies logic. are but a rare manifestation of portal 
obstruction. If a patient comes to you with haemorrhoids, start 
looking for a cause in the anorectal region, and not in the liver. 
(2) Portal vein thrombosis-Occurs in about 13 of cases, and may give 
rise to spreading mesenteric thrombosis. 
(3) Splenomegaly-This is thought to be due in part to the raised 
pressure. and in part to an actual hypertrophy. This latter theory 
is based on evidence obtained from transplantation of the spleens 
of rabbits under the skin of their abdominal walls, where a distinct 
hyperplasia was observed secondary to induced portal hyper-
tension. 
Cinical Features 
These can easily be worked out from the pathology. The most important 
is haemorrhage from the l'arices, which may be sudden and torrential. pre-
ceded by a salty taste at the back of the mouth, or so slow that the only 
symptom is breathlessness due to the secondary anaemia. After the bleed 
the patient may pass into coma. either due to shock or due to neuropathy 
consequent upon the absorption of blood from the gut. Characteristically 
the bleeds arc unpredictable. there being anything from days to years between 
them. The cause of bleeding has been attributed to: 
(a) Trauma of food particles. 
(b) Peptic ulceration (Learmonth), 
(c) Raised intra-abdominal pressure-which may increase the portal 
venous pressure by as much as 130 cm. of saline. for example 
in coughing. 
Splenomegaly, in conjunction with a heavy haematemesis, and in the 
absence of a ''peptic" history. should make one suspicious of portal hyper-
tension. Hypersplenism is the condition of splenomegaly associated with 
anaemia. leucopenia and thrombocytopenia. This. with the hepatomegaly 
which sometimes occurs concomitantly. has been referred to as "'Banti's 
syndrome," but this term should be abandoned now that the common factor 
of portal hypertension is recognised. Some of the anaemia is thought to be 
due to increased erythrophagocytosis of the cells which spend an unduly 
long time in the splenic pulp, but also blood is lost in the form of melaena. 
haematemesis and epistaxis. Thrombocytopenia is the barb upon the hook 
of oesophageal varices. No pathological process could have been more 
cunning than to provide a patient with a potential source of bleeding in 
the form of varices and then to deprive him of part of his clotting mechanism. 
If an experienced clinician. enwrapped in the worship of Bacchus. is 
unaware of this fact. what chance has the layman? 
Ascites is not a feature of hypertension per se, but occurs if there is 
associated liver damage. It has been variously ascribed to a localised 
manifestation of a generalised fluid retention due to failure of the liver to 
inactivate sodium retaining corticoids. to increased vascular permeability 
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consequent upon the local hypertension, and to low plasma albumin, and is 
more evident when the obstruction is post-sinusoidal than in pre-sinusoidal 
block. 
Signs of hepatic insufficiency may also be present. Thus there may be 
jaundice, with derangement of liver function tests, red palms, pigmentation 
of skin creases, spider naevi. xanthomata, and muscle wasting. 
The collateral circulation may make itself evident in the form of a Caput 
Medusae in intrahepatic obstruction. or dilated veins in the scar of an 
abdominal operation. As mentioned above, haemorrhoids cannot be taken 
D V  a classical sign of portal hypertension. 
Lastly, there may be symptoms of vague ill health-anorexia, mild 
indigestion, lassitude, and sometimes an ill-defined discomfort in the right 
hypochondrium. 
Diagnosis and Investigations 
The cardinal features of this disease are splenomegaly and haematemesis. 
There may be nothing else in the clinical examination to guide the physician, 
and often splenomegaly is the only evidence presented. But there remains 
a battery of investigations which should not fail to elucidate the true state 
of affairs within the abdomen. 
(l) Liver Function Tests may indicate that the liver is at fault, and 
help to decide the surgeon for or against a decompression opera-
tion (v. infra). It is important to realise that negative tests do 
not rule out liver pathology or portal hypertension. 
(2) Barium Swallow can be relied upon to visualise the varices as chains 
of rounded filling defects in at least 40% of cases. 
(3) Oesophagoscopy is suggested for doubtful cases, but I would hesitate 
to advise this for a patient with an acute bleed. 
(4) Splenic venography is perhaps the most decisive and useful test 
available, and is indispensible to the surgeon. Originally this 
was carried out via an omental vein at laparotomy. but recently 
the technique of percutaneous transplenic venography has been 
developed, in which a few ccs. of opaque medium arc injected 
into the splenic pulp. whence it is swept into the portal system 
which is therefore visualised. This is now a safe and effective 
procedure. 
Only a few months ago a new approach to venography was 
made. This time the hemiazygos system was visualised by an 
intra-costal injection of opaque medium. This was claimed to 
be useful in difficult diagnostic problems, but its value remains 
to be confirmed. 
(5) Liver Biopsy may be done only when the information it yields is 
going to influence the management of the patient, and when the 
blood clotting mechanisms hayc been proved satisfactory. 
(6) Peritoneoscopy has been developed for use when malignant disease 
of the liver is suspected. 
Treatment 
Before treatment is begun the diagnosis of hypertension with normal 
liver function, or hypertension with damaged liver should be established. 
This done. treatment is aimed at 
(I) Stopping the bleeding if it is occurring. 
(2) Management of liver insufficiency if present. 
(3) Reducing the portal pressure by surgical means. 
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But it must be realised that no treatment, in our present state of enlighten-
ment. will in any way alter the course of hepatic pathology. and we can 
provide only temporary relief. We can guide our patient safely through 
the rapids. but inevitably Niagara draws nearer. 
Firstly. the patient with signs of portal hypertension: the non-operative 
methods of reducing portal hypertension consist in:-
(a) A low salt diet (less than 5 grams per day). 
(b) Diuretics, either mersalyl or chlorothiazidc. 
Recent workers claim that quite dramatic results can come from treatment 
with chlorothiazidc. but we have to face up to the chronicity of this disease. 
and I think it would be fair to say that diuretic drugs have their place in 
cases of acute hypertension due to active hepatitis, during the pre-operative 
phase of chronic cases. and in patients for whom surgery is for some reason 
contra-i ndica tcd. 
What can he cat? With impaired liver function and in the absence 
of hepatic failure. he should be given a high protein diet with plenty of 
carbohydrate and added glucose. He must abstain completely from alcohol. 
and iron should be given to help him correct his anaemia. 
More often portal hypertension presents itself as an acute emergency--
as a haematemesis. The immediate measures to be taken are: rest in 
bed, transfusion and sedation. Care must be taken with morphia, which is 
detoxicated in the liver. and no more than 8 mg. should be given sub-
cutaneously. Apart from this one drawback it is an admirable drug. 
Having set up a blood drip. or plasma if there is no time to wait for 
blood. the next thing is to stop the blood loss. This is done by means of 
a Scngstaken-Blakcmorc tube. a three lumened tube with oesophageal and 
gastric balloons. The tube should not be left in situ for more than three 
days, since sloughing of the mucosa will then occur. 
A large quantity of blood has been lost into the gastrointestinal tract. 
and this is liable to give rise to hepatic coma due to reabsorption of 
nitrogenous products from the gut. As much of this as possible is removed 
via the gastric tube and by enema. and I gram of Neomycin Sulphate should 
be given in an attempt to reduce nitrogenous metabolism of the gut flora. 
Once resuscitated, the patient will have to undergo full investigation in 
order to decide future management- -surgery or not. 
We have now to consider the cold case- who has probably had one or 
two haematemcses. who is. at the moment. in fairly good general condition 
but whose future is. to say the least. doubtful. Into this category we may 
put our resuscitated patient mentioned above. We have come to the fork 
in the road medical or surgical treatment?- -and we do not know which 
way to turn. If we ask the sympathetic onlooker which way to go he will 
smile and say he's not very sure. and if we consult our map. it will show 
us that both roads F R P H  to an end not very far hence. 
Let us first consider the lessons learnt from 15 years of surgery in the 
portal system. In the first year after operation there is. in fact. a marked 
reduction in the incidence of subsequent haemorrhage as compared with 
medical series. Thereafter there is little to choose. but perhaps a slight 
advantage exists in surgical treatment. The surgical approach to patients 
with advanced liver disease has met with uniformly bad results. Perhaps 
a look at the criteria which must be satisfied before operation is undertaken 
will help us to decide what to do:-
(I) Age-patients 0ver 60 years of age do not do wc11 with surgery. 
(2) Recent jaundice -contra-indication. 
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(3) Active liver disease-a contra-indication. 
(4) Liver function tests-must show: 
Serum albumin: not less than 3 gm.   
Flocculation tests: if positive, must be only weakly so. 
Bromsulphalein: must be excreted to 70% within 30 minutes. 
(5) Ascites and Oedema-which fail to respond to medical treatment 
arc strong contra-indications. 
If our patient does not fit these rather stringent criteria, then medical 
treatment along the lines I have described should be instituted. 
The basis R I  definite surgical treatment is the creation of a porta-
systemic anastomosis. thus allowing decompression of the portal system 
Blakemore, the pioneer in this field. enunciated in 1945 three principles which 
still hold good: 
(I) That shunt operations arc designed to treat haemorrhage, and not 
ascites. 
(2) That shunts must be large. the only useful veins for the purpose being 
the portal and splenic veins. 
(3) That a shunt will function better the nearer it is to the obstruction. 
l. 
2. 
l. PoRTAcAVAL ANASTOMOSIS 
2. SPLENO 5 ( 1 $ /  ANASTOMOSIS 
Fig. 3 
The Portacaval Shunt 
This is undoubtedly the most efficient anastomosis, but that brings us up 
against the big problem of shunts straight away-the more efficient the shunt 
the more likely is neuropathy to develop. However, in view of the less 
satisfying results obtained from other procedures. it seems reasonable to 
hold to Milnes Walker's dictum that, having decided a shunt is necessary. 
the most efficient anastomosis possible should be created. The mechanics 
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of the anastomosis are shown in figure 3. As a decompressing procedure 
this works admirably, but it seems to me to be basically wrong to effect 
a total diversion of the portal blood (as in end-to-side anastomosis) from 
an organ which has a precarious oxygen supply at the best of times. The 
alternative of side-to-side anastomosis does not solve the problem. since 
on the reduction of pressure the flow of blood upwards from the site of 
junction to the liver becomes either non-existent or even reversed, a state 
of affairs that is conducive to thrombosis. It is a remarkable fact that all 
attempts at manometry have been made with the patient in the horizontal 
position. and it would be interesting to measure what effect the erect posture 
has upon the pressure gradient across an anastomosis, 
In cases where hypersplenism is present in sufficient degree to incapacitate 
the patient some workers advocate preliminary splenectomy. which is often 
followed by a reversion to normal of the blood dyscrasia. If this is done 
it is imperative to ensure that the portal vein is capable of being used later 
as a shunt. since the alternative splenorcnal anastomosis can no longer be 
done. In these cases I believe the Edinburgh practise is to perform a spleno-
renal anastomosis in the first instance. 
The Splenorenal Shunt 
Originally Blakemore used to remove the left kidney, but obviously this 
is unnecessary (see figure 3). The indications for splenorenal anastomosis at 
the present time arc: 
I. The indications for portacaval shunting. with 
2. an unsuitable portal vein, or 
3. severe hypersplenism, and 
4. a large splenic vein. 
It is a more formidable procedure, and less efficient as a shunt, and for 
this reason it was at one time advocated as the operation of choice on the 
basis that it produced the required decompression with minimal neuropathic 
symptoms. whilst conserving the normal hepatic inflow. However, because 
of the difficulty of thrombosis. this is no longer the operation of choice 
without specific indications. 
Operations on the Varices 
There remain a number of operations directed at the varices themselves. 
and which are resorted to when no suitable vein for anastomosis exists. 
or when neuropathy is a feature of the patient's illness. There are many 
such operations. and I propose merely to list them with a few comments 
here and there: 
1. Injection via the oesophagoscope. This merely destroys valuable 
porto-systcmic connections. and raises the pressure in those that 
remain. 
2 Gastric transection. 
3. Oesophageal transection with splenectomy. 
4. Ligature of the varices as an emergency procedure. 
5. Limited Oesophago-gastrectomy of use when other operations have 
been or cannot be attempted. 
6. Omentopexy-worthless. 
7. Ligature of the hepatic and other (splenic) arteries has been advocated 
in Russia in preference to shunt operations for patients with cirrhosis. 
b u t  after a few unsuccessful trials has commanded no great popularity 
i n the West. 
All these methods fail to prevent the recurrence of bleeding. later if 
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not sooner. Linton's idea that emergency ligature of the varices should 
give 3-4 weeks in which to improve. the patient's condition. prior to D Q D V 
tomosis seems sound, but even he hunself d1d not suggest It as definatJvc 
treatment. 
Portal Neuropathy : Theories 
As I mentioned earlier. the great difficulty of portal decompression is 
the likelihood of producing neuropathy by shunting the unfinished work of 
absorptive metabolism into the systemic circulation where the rough rocks 
of protein breakdown are crashed upon the gravel path of cerebral meta-
bolism. Or so it seems, for even yet we are not certain of the real cause 
of portal neuropathy. A rather inconstant relation with arterial ammonia 
concentration has been demonstrated. and patients being treated with 
Neomycin may suffer a rise in the blood ammonia level without clinical 
deterioration. It seems certain, however, that nitrogenous materials are 
causally related. since the two main precipitating factors arc haemorrhage 
into the gastro-intestinal tract, and a heavy protein meal, but what these 
materials arc, and what is their relationship to intestinal. liver and cerebral 
metabolism, nobody is yet prepared to say. Keto acids and amines have 
been accused, but not as yet proved guilty. There still remains the 
alternative that portal encephalopathy may be due to a deficiency, rather 
than an excess. of some factor: 5-hydroxy trpytophane has been suggested 
as a possibility in this sense. 
Results of Surgical Treatment 
The operative mortality has been variously reported from 9-15    being 
lowest in splcnorenal anastomosis because that operation is often done in 
cases of extrahepatic obstruction without gross liver damage. The main 
causes of fatality, according to Blakemore, are: 
I. Hepatic failure and neuropathy. 
2. Operative haemorrhage. 
3. Mesenteric thrombosis. 
4. Recurrent K D H P R U U K D J H  
A good demonstration of the superiority of portacaval anastomosis over the 
splenorenal type is given in Eckman's figures, in which 14 out of 32 patients 
with splenorenal anastomosis had recurrence of bleeding, while no recurrence 
at all was observed in 20 patients with a portacaval shunt, who were followed 
up for between one and seven years. 
The functional result is on the whole good. and it has been demonstrated 
here in Edinburgh that liver function is only temporarily depressed after 
anastomosis, and that no more than after gastrectomy. However, I would 
question anyone who asserted that no Jiver damage occurred in man: per-
manent damage certainly ensues in dogs subjected to a similar insult. 
Prognosis 
In his classical series on the dietary treatment of cirrhosis, Patek F R Q a 
eluded that I 8   of all cirrhotics died of gastro-intcstinal ha'morrhagc, and 
that about    of patients who bled were dead within a year of their first 
bleed. Other writers give different results, some more and others less 
favourable, but even the most optimistic figures demonstrate the hopeless-
ness of this condition 20 years ago, and though we have come a long way 
on the road to success, this is no time to rest on our laurels. It appears 
that in this condition, as in so many others, we must turn to the biochemist 
and the serologist to unlock for us doors that are as yet closed. 
[For References, see page 46 
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His fourth publication on renal disease-the Gulstonian lecture of 1833-
presented a summary of the signs he had come to associate with albuminous 
urine--anasarca, uraemia, absence of urea from the urine, infections. 
cardiac hypertrophy, cerebral symptoms and pathology of the kidneys. 
Bright died in 1838 at the height of a widespread and just reputation. 
His contribution to all branches of clinical research had been prolific-the 
heart. the liver, the spleen, the pancreas, the Gastro-intestinal tract, and the 
Central Nervous System-all had been faithfully observed in their pathological 
behaviour in life and appearance after death. He was a cheerful and 
attractive personality always careful to acknowledge the assistance of his 
juniors. In his heyday he had had no competition in research into kidney 
disease: the scope and detail of his own findings hardly encouraged it. But 
at the time of his death he had been retired from Guy's for 15 years, and 
would-be competitors, having sat back to take stock of the whole new 
concept. had in the meantime set the ball rolling again. So nephritis left 
Bright behind and emerged into the present century, where the successive 
efforts of Yolhard and Fahr, Dorothy Russell and Ellis to classify his 
disease have detracted nothing from, and added many complications to. the 
original simple account of Richard Bright himself. 
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